Rapport Therapeutics CEO Abraham Ceesay sells 51,499 shares worth $2.41 million
RAPP•CEO shares sale disclosed in SEC filing
- Rapport Therapeutics CEO Abraham Ceesay sold 51,499 common shares on Aug. 10-11.
- Sales prices ranged from $45.97 to $48.62 per share.
- Directly held stake fell to 486,108 shares.
- Indirect holdings totaled 102,458 shares through family trusts.
